227 related articles for article (PubMed ID: 33618909)
21. Stereotactic body radiotherapy for colorectal cancer liver metastases: A systematic review.
Petrelli F; Comito T; Barni S; Pancera G; Scorsetti M; Ghidini A;
Radiother Oncol; 2018 Dec; 129(3):427-434. PubMed ID: 29997034
[TBL] [Abstract][Full Text] [Related]
22. Risk-adapted stereotactic body radiation therapy for central and ultra-central early-stage inoperable non-small cell lung cancer.
Meng MB; Wang HH; Zaorsky NG; Sun BS; Zhu L; Song YC; Li FT; Dong Y; Wang JS; Chen HM; Yu XY; Yuan ZY
Cancer Sci; 2019 Nov; 110(11):3553-3564. PubMed ID: 31464032
[TBL] [Abstract][Full Text] [Related]
23. Clinical outcomes and prognostic factors of cyberknife stereotactic body radiation therapy for unresectable hepatocellular carcinoma.
Que J; Kuo HT; Lin LC; Lin KL; Lin CH; Lin YW; Yang CC
BMC Cancer; 2016 Jul; 16():451. PubMed ID: 27405814
[TBL] [Abstract][Full Text] [Related]
24. [Stereotactic body radiation therapy for hepatocellular carcinoma: Results from a retrospective multicentre study].
Scher N; Janoray G; Riet FG; Le Bayon AG; Debbi K; Lévy S; Louisot P; Garaud P; Chajon E; Barillot I; Salamé É; de Crevoisier R; Chapet S; Calais G
Cancer Radiother; 2019 Apr; 23(2):104-115. PubMed ID: 30952560
[TBL] [Abstract][Full Text] [Related]
25. Stereotactic radiation therapy for liver metastases: factors affecting local control and survival.
Andratschke NH; Nieder C; Heppt F; Molls M; Zimmermann F
Radiat Oncol; 2015 Mar; 10():69. PubMed ID: 25889512
[TBL] [Abstract][Full Text] [Related]
26. Curative-intent radiotherapy in patients with oligometastatic lesions from colorectal cancer: A single-center study.
He X; Zhang P; Li Z; Bi F; Xu F; Wang X; Shen Y; Li Q; Qiu M
Medicine (Baltimore); 2018 Oct; 97(40):e12601. PubMed ID: 30290630
[TBL] [Abstract][Full Text] [Related]
27. Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases.
Voglhuber T; Kessel KA; Oechsner M; Vogel MME; Gschwend JE; Combs SE
BMC Cancer; 2020 Jun; 20(1):536. PubMed ID: 32513136
[TBL] [Abstract][Full Text] [Related]
28. Linac-based stereotactic body radiation therapy for unresectable locally advanced pancreatic cancer: risk-adapted dose prescription and image-guided delivery.
Mazzola R; Fersino S; Aiello D; Gregucci F; Tebano U; Corradini S; Di Paola G; Cirillo M; Tondulli L; Ruffo G; Ruggieri R; Alongi F
Strahlenther Onkol; 2018 Sep; 194(9):835-842. PubMed ID: 29696321
[TBL] [Abstract][Full Text] [Related]
29. Hypofractionated image-guided breath-hold SABR (stereotactic ablative body radiotherapy) of liver metastases--clinical results.
Boda-Heggemann J; Dinter D; Weiss C; Frauenfeld A; Siebenlist K; Attenberger U; Ottstadt M; Schneider F; Hofheinz RD; Wenz F; Lohr F
Radiat Oncol; 2012 Jun; 7():92. PubMed ID: 22710033
[TBL] [Abstract][Full Text] [Related]
30. Stereotactic Ablative Radiation Therapy for Colorectal Liver Metastases.
McDermott RL; Dunne EM; Zhao Y; Bergman A; Liu MC; Schellenberg D; Ma RM
Clin Colorectal Cancer; 2023 Mar; 22(1):120-128. PubMed ID: 36526537
[TBL] [Abstract][Full Text] [Related]
31. Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis.
Chang DT; Swaminath A; Kozak M; Weintraub J; Koong AC; Kim J; Dinniwell R; Brierley J; Kavanagh BD; Dawson LA; Schefter TE
Cancer; 2011 Sep; 117(17):4060-9. PubMed ID: 21432842
[TBL] [Abstract][Full Text] [Related]
32. Dosimetric analysis of liver toxicity after liver metastasis stereotactic body radiation therapy.
Barry A; McPartlin A; Lindsay P; Wang L; Brierley J; Kim J; Ringash J; Wong R; Dinniwell R; Craig T; Dawson LA
Pract Radiat Oncol; 2017; 7(5):e331-e337. PubMed ID: 28442242
[TBL] [Abstract][Full Text] [Related]
33. Stereotactic Body Radiotherapy (SBRT) for liver metastasis - clinical outcomes from the international multi-institutional RSSearch® Patient Registry.
Mahadevan A; Blanck O; Lanciano R; Peddada A; Sundararaman S; D'Ambrosio D; Sharma S; Perry D; Kolker J; Davis J
Radiat Oncol; 2018 Feb; 13(1):26. PubMed ID: 29439707
[TBL] [Abstract][Full Text] [Related]
34. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.
Su TS; Lu HZ; Cheng T; Zhou Y; Huang Y; Gao YC; Tang MY; Jiang HY; Lian ZP; Hou EC; Liang P
BMC Cancer; 2016 Nov; 16(1):834. PubMed ID: 27809890
[TBL] [Abstract][Full Text] [Related]
35. Stereotactic Body Radiotherapy for Lung Metastases from Colorectal Cancer: Prognostic Factors for Disease Control and Survival.
Qiu H; Katz AW; Chowdhry AK; Usuki KY; Singh DP; Metcalfe S; Cheruvu P; Chen Y; Okunieff P; Milano MT
Am J Clin Oncol; 2018 Jan; 41(1):53-58. PubMed ID: 26270442
[TBL] [Abstract][Full Text] [Related]
36. Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study.
Milano MT; Katz AW; Zhang H; Okunieff P
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):878-86. PubMed ID: 22172903
[TBL] [Abstract][Full Text] [Related]
37. Stereotactic radiation therapy of brain metastases from colorectal cancer: A single institution cohort.
Paix A; Antoni D; Adeduntan R; Noël G
Cancer Radiother; 2017 May; 21(3):199-204. PubMed ID: 28499660
[TBL] [Abstract][Full Text] [Related]
38. Novel strategy in the treatment of liver metastases - Hepatic resection combined with stereotactic body radiotherapy.
Ihnát P; Skácelíková E; Vávra P; Jonszta T; Ihnát Rudinská L; Tomášková H
Asian J Surg; 2020 Sep; 43(9):902-906. PubMed ID: 31911035
[TBL] [Abstract][Full Text] [Related]
39. Survival and prognostic factors in 321 patients treated with stereotactic body radiotherapy for oligo-metastases.
Fode MM; Høyer M
Radiother Oncol; 2015 Feb; 114(2):155-60. PubMed ID: 25583567
[TBL] [Abstract][Full Text] [Related]
40. 30 Gy single dose stereotactic body radiation therapy (SBRT): Report on outcome in a large series of patients with lung oligometastatic disease.
Osti MF; Agolli L; Valeriani M; Reverberi C; Bracci S; Marinelli L; De Sanctis V; Cortesi E; Martelli M; De Dominicis C; Minniti G; Nicosia L
Lung Cancer; 2018 Aug; 122():165-170. PubMed ID: 30032826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
